Your browser doesn't support javascript.
loading
Artemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Grande Comore island: an open-label, non-randomised controlled trial.
Li, Guoming; Yuan, Yueming; Zheng, Shaoqin; Lu, Chenguang; Li, Mingqiang; Tan, Ruixiang; Zhang, Hongying; Silai, Rahamatou; Liu, Ruimei; Abdallah, Kamal Said; Bacar, Affane; Xu, Qin; Song, Jianping; Wu, Wanting; Deng, Changsheng.
Afiliação
  • Li G; Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
  • Yuan Y; Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China; Institution of Science and Technology Park, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
  • Zheng S; Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China; Institution of Science and Technology Park, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
  • Lu C; Zhang Zhongjing School of Chinese Medicine, Nanyang Institute of Technology, Nanyang, People's Republic of China.
  • Li M; Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
  • Tan R; Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
  • Zhang H; Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
  • Silai R; National Malaria Center of the Union of Comoros, Moroni, Grande Comore, The Union of Comoros.
  • Liu R; Institution of Science and Technology Park, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
  • Abdallah KS; National Malaria Center of the Union of Comoros, Moroni, Grande Comore, The Union of Comoros.
  • Bacar A; National Malaria Center of the Union of Comoros, Moroni, Grande Comore, The Union of Comoros.
  • Xu Q; Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
  • Song J; Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
  • Wu W; Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China. Electronic address: wuwanting73@163.com.
  • Deng C; Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China. Electronic address: dcs19811202@163.com.
Int J Antimicrob Agents ; 60(4): 106658, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35988664
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Malária Falciparum / Artemisininas / Malária / Antimaláricos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Malária Falciparum / Artemisininas / Malária / Antimaláricos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article